Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 9.390 +0.590 (+6.70%) Streaming Delayed Price Updated: 11:42 AM EDT, Jul 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 348,991 Open 8.760 Bid (Size) 9.380 (2) Ask (Size) 9.400 (3) Prev. Close 8.800 Today's Range 8.680 - 9.390 52wk Range 5.700 - 12.63 Shares Outstanding 121,613,181 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 To capitalize on the transition to more AI-focused drug development investors need to understand the drug development process and the financial health and market potential of those companies under... Via Talk Markets Expert Ratings For Relay Therapeutics July 17, 2024 Via Benzinga Performance YTD -20.79% -20.79% 1 Month +36.09% +36.09% 3 Month +57.82% +57.82% 6 Month -8.12% -8.12% 1 Year -22.65% -22.65% More News Read More Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Via Talk Markets Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Via Talk Markets Expert Ratings For Relay Therapeutics June 07, 2024 Via Benzinga Key Takeaways From Relay Therapeutics Analyst Ratings May 10, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 Via Talk Markets Relay Therapeutics Discloses Three New Programs at New Program & Platform Event June 06, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608 June 05, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 Via Talk Markets Relay Therapeutics to Participate in Upcoming Investor Conferences May 21, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Host New Program and Platform Event on June 6, 2024 May 13, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire 5 Of 7 AI Categories Rose, Slightly,Over Past Week May 11, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence The 7 AI Categories Declined, On Average, The First Week Of May May 05, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May May 05, 2024 Via Talk Markets RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 Via InvestorPlace Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights May 02, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024 April 25, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week April 23, 2024 Via Talk Markets Relay Therapeutics to Participate in Upcoming Investor Conferences April 11, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's After-Market Session April 10, 2024 Via Benzinga AI Surge Ending: Only One Category Was Up This Week April 06, 2024 Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence 3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise March 15, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
